Tenet Healthcare (THC) Given Daily Media Impact Score of 0.26
News stories about Tenet Healthcare (NYSE:THC) have trended positive recently, according to Accern. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tenet Healthcare earned a news impact score of 0.26 on Accern’s scale. Accern also gave press coverage about the company an impact score of 44.1604721825109 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:
- What Technical Analysis say About Tenet Healthcare Corp. (NYSE:THC)? – The Oracle Examiner (oracleexaminer.com)
- In boon to securities plaintiffs, 6th Circuit pushes loss causation bounds (reuters.com)
- CHS $891 million securities fraud lawsuit gets a second life (modernhealthcare.com)
- J P Morgan Chase & Co Downgrades Tenet Healthcare (THC) to Underweight (americanbankingnews.com)
- What Does Tenet Healthcare Corp’s (NYSE:THC) Share Price Indicate? (finance.yahoo.com)
Shares of Tenet Healthcare (NYSE:THC) opened at $14.34 on Friday. Tenet Healthcare has a 1-year low of $12.25 and a 1-year high of $22.72. The company has a quick ratio of 1.21, a current ratio of 1.28 and a debt-to-equity ratio of 21.21.
THC has been the subject of several recent research reports. Mizuho restated a “neutral” rating and set a $14.00 price objective on shares of Tenet Healthcare in a report on Thursday, September 14th. J P Morgan Chase & Co downgraded Tenet Healthcare from a “neutral” rating to an “underweight” rating and set a $15.00 price target for the company. in a report on Thursday. Jefferies Group reiterated a “buy” rating and set a $24.00 price target on shares of Tenet Healthcare in a report on Thursday, September 21st. Royal Bank of Canada decreased their price target on Tenet Healthcare from $19.00 to $17.00 and set a “sector perform” rating for the company in a report on Monday, November 13th. Finally, Leerink Swann reiterated an “outperform” rating and set a $30.00 price target (up previously from $23.00) on shares of Tenet Healthcare in a report on Sunday, August 20th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $18.73.
COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.watchlistnews.com/tenet-healthcare-thc-given-daily-media-impact-score-of-0-26/1768935.html.
About Tenet Healthcare
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.